Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy

Overview of attention for article published in Cancers, June 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 83 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 30 publications that cite this research output.

30

The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.

Water-soluble Pillar[5]arene-based drug candidates for lung and breast cancer

Article in Journal of Biomolecular Structure and Dynamics (March 2024)

Moving beyond traditional therapies: the role of nanomedicines in lung cancer

Article in Frontiers in Pharmacology (February 2024)

The multifaceted role of Fragile X-Related Protein 1 (FXR1) in cellular processes: an updated review on cancer and clinical applications

Article in Cell Death & Disease (January 2024)